Ludesi Corporation, developer of the award-winning Ludesi Image Analysis Service and the Ludesi REDFIN software for two-dimensional electrophoresis gels, today announced the appointment of Lars Eric Utterman as the new chairman of Ludesi's Board of Directors. Mr. Utterman has a distinguished career in the biotechnology, diagnostics and pharmaceutical industries with more than 30 years experience [...]

As a part of its continued commitment to environmental sustainability, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced its participation in the U.S. Environmental Protection Agency's (EPA's) Climate Leaders program. By participating in Climate Leaders, Invitrogen has pledged to reduce its corporate-wide greenhouse gas emissions. Climate [...]

Scripps Translational Science Institute, Navigenics, Affymetrix and Microsoft team on groundbreaking health study SAN DIEGO, Oct. 9 -- A consortium of health care, technology and research leaders have joined forces in a first-of-its-kind research study to assess the behavioral impact of personal genetic testing on people who choose to receive such screenings to identify their [...]

Billerica, Massachusetts—September 8, 2008—Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, and VigeneTech, today announced the launch of the powerful MILLIPLEX™ Analyst software. This customized OEM software made from VigeneTech is the only data analysis package that is seamlessly integrated with Luminex xPONENT software, the system [...]

Celera (NASDAQ:CRA) today announced the appointment of Christopher Hall as Chief Business Officer of Berkeley HeartLab (BHL), effective immediately. Mr. Hall succeeds Frank Ruderman, the former Chairman and CEO of BHL, who is leaving the company to pursue other interests following the successful integration of BHL into Celera. Mr. Ruderman will consult for Celera during [...]

BILLERICA, Mass., Oct. 6 -- Seahorse Bioscience todayannounced the release of the first ever analytical instrument for the kineticmeasurement of mitochondrial oxygen consumption and cytoplasmic glycolysis incells in a 96 well microplate. For the past 75 years tools for measuringcellular bioenergetics have been relatively unchanged since Warburg designedthe Warburg Apparatus in 1932 and Leland Clark [...]

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today congratulates the three winners of the 2008 Nobel Prize in chemistry: Drs. Roger Tsien, Osamu Shimomura and Martin Chalfie, all of whom contributed to developing and expanding the use of fluorescent proteins in biological applications. Fluorescent proteins, including those [...]

Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new Muse(TM) de novo design product, which is targeted for commercial release in the fourth quarter [...]

LIBERTYVILLE, Ill. & CARLSBAD, Calif. & WOODRIDGE, Ill.--Families of Spinal Muscular Atrophy (FSMA, www.curesma.org), Invitrogen Corporation (NASDAQ:IVGN)(www.invitrogen.com), and deCODE chemistry & biostructures (www.decodechembio.com) announced today they have identified a protein that is a potential molecular target for the treatment of Spinal Muscular Atrophy (SMA). In its most severe form, SMA often leads to death in [...]

SOUTH EASTON, Mass., Oct. 8 -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") today provided an update on various corporate activities, including the presentation of favorable data generated by scientists at Amgen, Inc. on the Company's pressure cycling technology ("PCT"), the scheduled presentation by Dr. Paul Pevsner of the NYU School of Medicine on the use [...]